Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A B Smulevich

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 18, 2021
[Cariprazine in schizophrenia with predominantly negative symptoms: early effects of therapy (observational study)]A B Smulevich, S V Ivanov, K K Yakhin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 29, 2023
[Bimodal model of delusional psychoses (on the problem of the correlation of paranoid dimensions in the psychopathological space of schizophrenia)]A B Smulevich, T P Klyushnik, D V Romanov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 17, 2015
[The Four-Dimensional Symptom Questionnaire (4DSQ) to assess distress, depression, anxiety and somatization in autonomic and borderline psychosomatic disorders]A B Smulevich, N N Yakhno, B Terluin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|May 13, 1999
[Psychosomatic disorders (clinical picture, epidemiology, therapy and models of health services]A B Smulevich, A L Syrkin, V N Kozyrev, et al.
BMC Research Notes|December 15, 2015
The linguistic validation of Russian version of Dutch four-dimensional symptoms questionnaire (4DSQ) for assessing distress, depression, anxiety and somatization in patients with borderline psychosomatic disordersV S Arnautov, D V Reyhart, A B Smulevich, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 16, 2016
[Comorbidity of depression and nonaffective - schizophrenia spectrum disorders: the clinical-epidemiological study EDIP]A B Smulevich, N I Briko, A V Andryushchenko, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|July 20, 2010
[The use of mGlu2/3 receptors as a new approach to treat schizophrenia: results of a randomized double-blind trial]S N Mosolov, A B Smulevich, N G Neznanov, et al.
Kardiologiia|September 2, 2004
[Anginal States provoked by psychogenic stimuli. To the problem of psychosomatic reactions in patients with ischemic heart disease]A B Smulevich, A L Syrkin, V A Sulimov, et al.
Bulletin of Experimental Biology and Medicine|September 11, 2001
The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activityA A Zozulya, N V Kost, O Yu Sokolov, et al.
Bulletin of Experimental Biology and Medicine|February 13, 2025
MRI Study of the Brain Structural Characteristic in Persecutory DelusionsA S Tomyshev, A N Dudina, E V Ilina, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 18, 2021
[Cariprazine in schizophrenia with predominantly negative symptoms: early effects of therapy (observational study)]A B Smulevich, S V Ivanov, K K Yakhin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 29, 2023
[Bimodal model of delusional psychoses (on the problem of the correlation of paranoid dimensions in the psychopathological space of schizophrenia)]A B Smulevich, T P Klyushnik, D V Romanov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 17, 2015
[The Four-Dimensional Symptom Questionnaire (4DSQ) to assess distress, depression, anxiety and somatization in autonomic and borderline psychosomatic disorders]A B Smulevich, N N Yakhno, B Terluin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|May 13, 1999
[Psychosomatic disorders (clinical picture, epidemiology, therapy and models of health services]A B Smulevich, A L Syrkin, V N Kozyrev, et al.
BMC Research Notes|December 15, 2015
The linguistic validation of Russian version of Dutch four-dimensional symptoms questionnaire (4DSQ) for assessing distress, depression, anxiety and somatization in patients with borderline psychosomatic disordersV S Arnautov, D V Reyhart, A B Smulevich, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 16, 2016
[Comorbidity of depression and nonaffective - schizophrenia spectrum disorders: the clinical-epidemiological study EDIP]A B Smulevich, N I Briko, A V Andryushchenko, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|July 20, 2010
[The use of mGlu2/3 receptors as a new approach to treat schizophrenia: results of a randomized double-blind trial]S N Mosolov, A B Smulevich, N G Neznanov, et al.
Kardiologiia|September 2, 2004
[Anginal States provoked by psychogenic stimuli. To the problem of psychosomatic reactions in patients with ischemic heart disease]A B Smulevich, A L Syrkin, V A Sulimov, et al.
Bulletin of Experimental Biology and Medicine|September 11, 2001
The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activityA A Zozulya, N V Kost, O Yu Sokolov, et al.
Bulletin of Experimental Biology and Medicine|February 13, 2025
MRI Study of the Brain Structural Characteristic in Persecutory DelusionsA S Tomyshev, A N Dudina, E V Ilina, et al.
Pageof 12